Crowdonomics
O2 RegenTech

Reg CF · Common Stock · Nov 2023

WithdrawnReg CFCommon Equity
via NetcapitalView campaign
Raised
$2K / $612K max
0% of ceiling
Investors
—
—
Post-money valuation
$6.8M
pre-money + amount raised

Raised over time

Cumulative raised
$2K$1K$0
Nov 5, 2023 · openedApr 30, 2025 · last reading
Deadline Apr 30, 2025 — 0 days out

Left axis: cumulative dollars raised. Live figures via Netcapital; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2021–FY2022 · hover for source
$0
−$53K
FY2021
$0
−$18K
FY2022
RevenueNet income
Metric
FY2021 reviewed
FY2022 reviewed
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
-$53,064
-$18,280
Taxes paid
$0
$0
Balance sheet
Cash
$201
$1,032
Accounts receivable
$0
$0
Total assets
$201
$1,032
Short-term debt
$50,000
$50,000
Long-term debt
$204,500
$223,500
Total liabilities
$254,500
$273,500
Other
Headcount
—
0

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

7 amendments
  1. Mar 20, 2025
    • Deadline Apr 1, 2025 → Apr 30, 2025

    “issuer extended the offering deadline.”

    Form C/A on EDGAR ↗
  2. Jan 10, 2025
    • Deadline Jan 17, 2025 → Apr 1, 2025

    “issuer extended the offering deadline.”

    Form C/A on EDGAR ↗
  3. Oct 30, 2024
    • Deadline Oct 31, 2024 → Jan 17, 2025

    “issuer extended the offering deadline.”

    Form C/A on EDGAR ↗
  4. Jul 25, 2024
    • Deadline Jul 31, 2024 → Oct 31, 2024

    “issuer extended the offering deadline.”

    Form C/A on EDGAR ↗
  5. Apr 22, 2024
    • Deadline Apr 27, 2024 → Jul 31, 2024

    “issuer extended the offering deadline and updated the offering statement to include 2023 financial information.”

    Form C/A on EDGAR ↗
  6. Mar 20, 2024
    • Deadline Mar 29, 2024 → Apr 27, 2024

    “issuer extended the offering”

    Form C/A on EDGAR ↗
  7. Jan 16, 2024
    • Deadline Jan 26, 2024 → Mar 29, 2024

    “issuer extended the offering deadline.”

    Form C/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.

Deal terms

Pre-money$6.8M
Post-money$6.8M
Price / share$6.80
Shares offered1,471

Offering details

Target$10,003
Max$612,000
Min investment$102
OpenedNov 5, 2023
DeadlineApr 30, 2025
ClosedApr 30, 2025
Days active542

Links & provenance

Source: Manual
0001669191-23-001054

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.